Jules Haimovitz is Director of Innoviva, Inc.. Currently has a direct ownership of 130,829 shares of INVA, which is worth approximately $2.51 Million. The most recent transaction as insider was on Jun 17, 2024, when has been sold 13,923 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K
0% 3M change
11.91% 12M change
Total Value Held $2.51 Million

Jules Haimovitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2024
BUY
Grant, award, or other acquisition
-
13,923 Added 9.62%
130,829 Common Stock
May 22 2023
BUY
Grant, award, or other acquisition
-
16,495 Added 12.36%
116,906 Common Stock
Apr 25 2022
BUY
Grant, award, or other acquisition
-
12,647 Added 11.19%
100,411 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
-
17,482 Added 16.61%
87,764 Common Stock

Also insider at

ARMP
Armata Pharmaceuticals, Inc. Healthcare
JH

Jules Haimovitz

Director
Marina Del Rey, CA

Track Institutional and Insider Activities on INVA

Follow Innoviva, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INVA shares.

Notify only if

Insider Trading

Get notified when an Innoviva, Inc. insider buys or sells INVA shares.

Notify only if

News

Receive news related to Innoviva, Inc.

Track Activities on INVA